BioNTech SE plans to acquire Tunisian-founded, United Kingdom-based InstaDeep for up to £562 million (about $680 million). This will be BioNTech SE’s largest deal to date. According to the Financial Times, the German vaccine manufacturer plans to employ the machine learning capabilities of InstaDeep to better its drug discovery process. This will include the development … Continue reading BioNTech acquires Tunisian startup InstaDeep for £562 million